Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts
Download
Download
Download
Full text for this resource is not available from the Research Repository.
Export
Akiyama, Toru, Dass, Crispin R, Shinoda, Y, Kawano, H, Tanaka, Sakae and Choong, Peter F. M (2010) Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts. Journal of Pharmacy and Pharmacology, 62 (4). pp. 470-476. ISSN 0022-3573
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/7570 |
| Subjects | Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences Historical > FOR Classification > 0304 Medicinal and Bimolecular Chemistry Historical > FOR Classification > 1112 Oncology and Carcinogenesis Historical > SEO Classification > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) |
| Keywords | ResPubID21865. osteoclast, osteosarcoma, bone cancer, RANK, RANKL, tumours, protein therapy |
| Citations in Scopus | 27 - View on Scopus |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)